Profile | GDS5420 / 210964_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 42.35 | 29 |
GSM1296119 | B_lesional_pre-dose | 46.16 | 27 |
GSM1296076 | C_lesional_pre-dose | 48.87 | 30 |
GSM1296092 | D_lesional_pre-dose | 53.49 | 34 |
GSM1296103 | E_lesional_pre-dose | 41.61 | 29 |
GSM1296078 | F_lesional_pre-dose | 106.51 | 44 |
GSM1296107 | G_lesional_pre-dose | 306.6 | 59 |
GSM1296109 | H_lesional_pre-dose | 61.29 | 32 |
GSM1296080 | I_lesional_pre-dose | 32.91 | 26 |
GSM1296090 | J_lesional_pre-dose | 61.43 | 35 |
GSM1296074 | K_lesional_pre-dose | 32.5 | 26 |
GSM1296111 | L_lesional_pre-dose | 80.92 | 36 |
GSM1296099 | M_lesional_pre-dose | 71.9 | 36 |
GSM1296086 | O_lesional_pre-dose | 107.46 | 44 |
GSM1296117 | P_lesional_pre-dose | 49.24 | 27 |
GSM1296113 | Q_lesional_pre-dose | 105.14 | 39 |
GSM1296096 | R_lesional_pre-dose | 76.37 | 38 |
GSM1296105 | S_lesional_pre-dose | 274.79 | 57 |
GSM1296098 | T_lesional_pre-dose | 63.17 | 33 |
GSM1296101 | U_lesional_pre-dose | 170.47 | 49 |
GSM1296121 | V_lesional_pre-dose | 100.46 | 40 |
GSM1296088 | W_lesional_pre-dose | 71.97 | 37 |
GSM1296082 | X_lesional_pre-dose | 10.95 | 12 |
GSM1296115 | Y_lesional_pre-dose | 179.13 | 50 |
GSM1296084 | Z_lesional_pre-dose | 104.63 | 42 |
GSM1296072 | B_lesional_day8 | 52.05 | 30 |
GSM1296069 | L_lesional_day8 | 118.39 | 41 |
GSM1296071 | P_lesional_day8 | 92.97 | 37 |
GSM1296070 | Y_lesional_day8 | 242.26 | 54 |
GSM1296073 | V_lesional_day8 | 74.63 | 36 |
GSM1296034 | A_lesional_day15 | 54.84 | 31 |
GSM1296041 | G_lesional_day15 | 195.87 | 52 |
GSM1296035 | R_lesional_day15 | 47.96 | 32 |
GSM1296038 | U_lesional_day15 | 409.83 | 64 |
GSM1296047 | B_lesional_day15 | 73.87 | 34 |
GSM1296039 | E_lesional_day15 | 57.02 | 33 |
GSM1296042 | H_lesional_day15 | 137.3 | 44 |
GSM1296043 | L_lesional_day15 | 85.76 | 36 |
GSM1296037 | M_lesional_day15 | 115.25 | 43 |
GSM1296046 | P_lesional_day15 | 90.76 | 37 |
GSM1296044 | Q_lesional_day15 | 287.5 | 57 |
GSM1296045 | Y_lesional_day15 | 431.03 | 65 |
GSM1296025 | C_lesional_day15 | 195.37 | 53 |
GSM1296033 | D_lesional_day15 | 131.14 | 46 |
GSM1296027 | I_lesional_day15 | 83.23 | 41 |
GSM1296032 | J_lesional_day15 | 349.09 | 61 |
GSM1296024 | K_lesional_day15 | 132.29 | 47 |
GSM1296031 | W_lesional_day15 | 783.63 | 75 |
GSM1296028 | X_lesional_day15 | 65.78 | 35 |
GSM1296029 | Z_lesional_day15 | 96.44 | 41 |
GSM1296026 | F_lesional_day15 | 68.72 | 36 |
GSM1296030 | O_lesional_day15 | 70.41 | 39 |
GSM1296040 | S_lesional_day15 | 193.1 | 52 |
GSM1296036 | T_lesional_day15 | 63.56 | 33 |
GSM1296048 | V_lesional_day15 | 127.96 | 44 |
GSM1296059 | A_lesional_day43 | 67.91 | 37 |
GSM1296066 | G_lesional_day43 | 246.41 | 55 |
GSM1296060 | R_lesional_day43 | 80.51 | 38 |
GSM1296063 | U_lesional_day43 | 719.6 | 74 |
GSM1296064 | E_lesional_day43 | 74.76 | 38 |
GSM1296067 | H_lesional_day43 | 122.09 | 42 |
GSM1296062 | M_lesional_day43 | 72.41 | 36 |
GSM1296068 | Q_lesional_day43 | 934.33 | 78 |
GSM1296050 | C_lesional_day43 | 576.86 | 70 |
GSM1296057 | D_lesional_day43 | 151.39 | 48 |
GSM1296052 | I_lesional_day43 | 105.19 | 44 |
GSM1296054 | J_lesional_day43 | 40.26 | 27 |
GSM1296049 | K_lesional_day43 | 141.25 | 47 |
GSM1296055 | W_lesional_day43 | 524.27 | 68 |
GSM1296053 | X_lesional_day43 | 62.79 | 34 |
GSM1296058 | Z_lesional_day43 | 138.54 | 47 |
GSM1296051 | F_lesional_day43 | 107.67 | 43 |
GSM1296056 | O_lesional_day43 | 120.13 | 46 |
GSM1296065 | S_lesional_day43 | 537.3 | 69 |
GSM1296061 | T_lesional_day43 | 97.37 | 40 |
GSM1296095 | A_non-lesional_pre-dose | 85.25 | 40 |
GSM1296120 | B_non-lesional_pre-dose | 53.51 | 29 |
GSM1296077 | C_non-lesional_pre-dose | 293.38 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 172.29 | 49 |
GSM1296104 | E_non-lesional_pre-dose | 81.51 | 38 |
GSM1296079 | F_non-lesional_pre-dose | 119.42 | 45 |
GSM1296108 | G_non-lesional_pre-dose | 548.02 | 69 |
GSM1296110 | H_non-lesional_pre-dose | 119.09 | 41 |
GSM1296081 | I_non-lesional_pre-dose | 1035.85 | 79 |
GSM1296091 | J_non-lesional_pre-dose | 44.75 | 30 |
GSM1296075 | K_non-lesional_pre-dose | 234.21 | 56 |
GSM1296112 | L_non-lesional_pre-dose | 361.21 | 61 |
GSM1296100 | M_non-lesional_pre-dose | 220.98 | 53 |
GSM1296087 | O_non-lesional_pre-dose | 179.98 | 53 |
GSM1296118 | P_non-lesional_pre-dose | 100.75 | 38 |
GSM1296114 | Q_non-lesional_pre-dose | 147 | 45 |
GSM1296097 | R_non-lesional_pre-dose | 91.23 | 40 |
GSM1296106 | S_non-lesional_pre-dose | 244.03 | 55 |
GSM1296102 | U_non-lesional_pre-dose | 223.98 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 259.07 | 56 |
GSM1296089 | W_non-lesional_pre-dose | 152.41 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 837.75 | 76 |
GSM1296116 | Y_non-lesional_pre-dose | 324.21 | 59 |
GSM1296085 | Z_non-lesional_pre-dose | 146.64 | 47 |